The Mometasone Furoate Market overview:
Mometasone furoate is a corticosteroid used to treat skin conditions such as eczema, psoriasis, and rashes. It works by reducing swelling, itching, and allergic reactions. Applied topically as a cream, ointment, or lotion, mometasone furoate is very effective in relieving symptoms of inflammatory skin conditions. It has minimal to no systemic absorption and thus has a good safety profile. There is an increasing demand for mometasone furoate products due to rising cases of inflammatory skin disorders.

Global mometasone furoate market is estimated to be valued at US$ 1,182.9 million in 2022, and is expected to exhibit a CAGR 7.4% over the forecast period (2022-2030).

Key Takeaways
Key players operating in the Mometasone Furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Miltenyi Biotec, Takara Bio Group, CellGenix GmbH, FUJIFILM Irvine Scientific, Agilent Technologies, Bio-Techne Corporation, Bio-Rad Laboratories, BD, Charles River Laboratories, Creative Bioarray, Sartorius AG, Novogene Corporation, AGC Biologics, Catalent, and WuXi AppTec. The rising prevalence of allergies and advancement of drug delivery systems provide key opportunities in this market. Drug makers are focusing on novel topical formulations like foams, gels, and spray-on products for better treatment compliance.

Market drivers:
The growing geriatric population prone to inflammatory skin diseases is a major Mometasone Furoate Market Demand driver. According to estimates, over 60% of people aged 65 years and above suffer from some form of skin disorder. Innovation in novel drug delivery technologies is also fueling the mometasone furoate market. Patented technologies like thin film, nanotechnology-based products promise improved efficacy and reduced dosing frequency.

Get More Insights on- Mometasone Furoate Market